This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vitamin C purchasers file reply in support of US high court review of price-fixing case against Chinese manufacturers

( July 6, 2022, 22:31 GMT | Official Statement) -- MLex Summary: Plaintiffs bringing US price-fixing claims against Chinese manufacturers of vitamin C filed a reply in support of the Supreme Court reviewing an appeals court decision affirming dismissal of their claims on remand. “Under the decision below, the Sherman Act has no fixed meaning. The Act’s text is irrelevant. All that matters in a given case is how a single judge decides to balance a judicially-invented list of policy-laden factors designed to guess how Congress might have applied the statute to that case,” they argued.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections